E. Arne Høiby

7.7k total citations · 1 hit paper
155 papers, 6.0k citations indexed

About

E. Arne Høiby is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, E. Arne Høiby has authored 155 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Epidemiology, 84 papers in Microbiology and 27 papers in Infectious Diseases. Recurrent topics in E. Arne Høiby's work include Bacterial Infections and Vaccines (82 papers), Pneumonia and Respiratory Infections (81 papers) and Streptococcal Infections and Treatments (21 papers). E. Arne Høiby is often cited by papers focused on Bacterial Infections and Vaccines (82 papers), Pneumonia and Respiratory Infections (81 papers) and Streptococcal Infections and Treatments (21 papers). E. Arne Høiby collaborates with scholars based in Norway, United States and Poland. E. Arne Høiby's co-authors include Dominique A. Caugant, Einar Rosenqvist, L O Frøholm, Elisabeth Wedege, G Bjune, Ingeborg S. Aaberge, Hanne Nøkleby, Peter R. Martin, Terje E. Michaelsen and Julia Chelsom and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

E. Arne Høiby

149 papers receiving 5.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

1991 583 citations G Bjune, E. Arne Høiby et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Arne Høiby Norway	39	3.8k	3.6k	1.0k	1.0k	775	155	6.0k
Mary Slack United Kingdom	44	5.7k 1.5×	3.4k 0.9×	685 0.7×	709 0.7×	393 0.5×	160	7.7k
Hans O. Hallander Sweden	41	3.3k 0.9×	2.9k 0.8×	1.3k 1.3×	365 0.4×	308 0.4×	124	5.0k
Cécile Bébéar France	53	3.8k 1.0×	4.8k 1.3×	866 0.8×	604 0.6×	486 0.6×	311	7.9k
Birger Trollfors Sweden	39	3.2k 0.8×	2.3k 0.6×	1.3k 1.2×	804 0.8×	328 0.4×	200	5.4k
C C Kuo United States	40	2.9k 0.8×	4.5k 1.2×	535 0.5×	501 0.5×	1.3k 1.6×	72	5.7k
Cho‐Chou Kuo United States	36	2.6k 0.7×	3.9k 1.1×	389 0.4×	501 0.5×	1.2k 1.6×	96	5.4k
Deborah F. Talkington United States	30	2.3k 0.6×	1.9k 0.5×	731 0.7×	726 0.7×	425 0.5×	62	4.0k
Muhamed‐Kheir Taha France	43	4.6k 1.2×	5.1k 1.4×	761 0.7×	562 0.6×	1.4k 1.7×	256	7.8k
J Henrichsen Denmark	35	2.2k 0.6×	1.1k 0.3×	774 0.8×	1.5k 1.5×	346 0.4×	104	4.4k
Carl F. Marrs United States	43	2.6k 0.7×	1.3k 0.3×	1.2k 1.2×	688 0.7×	281 0.4×	147	6.3k

Countries citing papers authored by E. Arne Høiby

Since Specialization

Citations

This map shows the geographic impact of E. Arne Høiby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Arne Høiby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Arne Høiby more than expected).

Fields of papers citing papers by E. Arne Høiby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Arne Høiby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Arne Høiby. The network helps show where E. Arne Høiby may publish in the future.

Co-authorship network of co-authors of E. Arne Høiby

This figure shows the co-authorship network connecting the top 25 collaborators of E. Arne Høiby. A scholar is included among the top collaborators of E. Arne Høiby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Arne Høiby. E. Arne Høiby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gammelsrud, Karianne Wiger, Per Kristian Knudsen, & E. Arne Høiby. (2016). A novel Direct MIC-gradient Strip Method to screen for antibiotic-resistant faecal Enterobacteriaceae. Journal of Microbiological Methods. 129. 94–97. 2 indexed citations

Gammelsrud, Karianne Wiger, Per Sandven, E. Arne Høiby, et al.. (2011). Colonization by Candida in children with cancer, children with cystic fibrosis, and healthy controls. Clinical Microbiology and Infection. 17(12). 1875–1881. 32 indexed citations

Torfoss, Dag, E. Arne Høiby, Harald Holte, & Stein Kvaløy. (2011). The Norwegian experience with penicillin G plus an aminoglycoside as initial empiric therapy in febrile neutropenia; a review. Acta Oncologica. 51(4). 433–440. 7 indexed citations

Nesbakken, Truls, Jørgen Fr Lassen, Karin Nygård, et al.. (2008). Salmonella diarizonae hos dyr i Norge Konsekvenser for dyr og mennesker. Uttalelse av Faggruppe for hygiene og smittestoffer og Faggruppe for dyrehelse og dyrevelferd (dyrevern). BIBSYS Brage (BIBSYS (Norway)). 1 indexed citations

Høiby, E. Arne, Didrik F. Vestrheim, Dominique A. Caugant, & Karianne Wiger Gammelsrud. (2008). Bakteriell resistens mot antibiotika. Tidsskrift for Den Norske Laegeforening.

Johannessen, Gro S., E. Arne Høiby, Georg Kapperud, et al.. (2008). Risk assessment of import and dissemination of intestinal pathogenic bacteria via fresh herbs and leafy vegetables from South-East Asia. Opinion of the Panel on Biological Hazards. Duo Research Archive (University of Oslo). 6 indexed citations

Littauer, Pia, et al.. (2007). Rapid Spread in Norway of an Erythromycin-Resistant Pneumococcal Clone, Despite Low Usage of Macrolides. Microbial Drug Resistance. 13(1). 29–36. 18 indexed citations

Yazdankhah, Siamak Pour, Anne A. Scheie, E. Arne Høiby, et al.. (2006). Triclosan and Antimicrobial Resistance in Bacteria: An Overview. Microbial Drug Resistance. 12(2). 83–90. 269 indexed citations

Wasteson, Yngvild, Kåre Fossum, E. Arne Høiby, et al.. (2006). A qualitative assessment of the risks of transmission of microorganisms to humans resulting from the consumption of raw milk and raw cream in Norway. Panel for Biological Hazards, Norwegian Scientific Committee for Food Safety. BIBSYS Brage (BIBSYS (Norway)). 1 indexed citations

10.

Littauer, Pia, Maria Sangvik, Dominique A. Caugant, et al.. (2005). Molecular Epidemiology of Macrolide-Resistant Isolates of Streptococcus pneumoniae Collected from Blood and Respiratory Specimens in Norway. Journal of Clinical Microbiology. 43(5). 2125–2132. 20 indexed citations

11.

Øvstebø, Reidun, P Brandtzæg, Berit Brusletto, et al.. (2004). Use of Robotized DNA Isolation and Real-Time PCR To Quantify and Identify Close Correlation between Levels of Neisseria meningitidis DNA and Lipopolysaccharides in Plasma and Cerebrospinal Fluid from Patients with Systemic Meningococcal Disease. Journal of Clinical Microbiology. 42(7). 2980–2987. 91 indexed citations

12.

Høiby, E. Arne, et al.. (2000). Aminoethyl-isothiourea, a nitric oxide synthase inhibitor and oxygen radical scavenger, improves survival and counteracts hemodynamic deterioration in a porcine model of streptococcal shock. Critical Care Medicine. 28(8). 2697–2706. 16 indexed citations

13.

Toropainen, Maija, Helena Käyhty, Leena Saarinen, et al.. (1999). The infant rat model adapted to evaluate human sera for protective immunity to group B meningococci1Presented in part at The Tenth International Pathogenic Neisseria Conference, Baltimore, MD, USA, September 8–13, 1996.1. Vaccine. 17(20-21). 2677–2689. 26 indexed citations

14.

Lehmann, Anne Kristine, A Digranes, Dominique A. Caugant, et al.. (1999). Outbreak of meningococcal disease in western Norway due to a new serogroup C variant of the ET-5 clone: effect of vaccination and selective carriage eradication. Epidemiology and Infection. 123(3). 373–382. 19 indexed citations

15.

Andersen, Svein Rune, Jan Kolberg, E. Arne Høiby, et al.. (1997). Lipopolysaccharide heterogeneity and escape mechanisms ofNeisseria meningitidis: possible consequences for vaccine development. Microbial Pathogenesis. 23(3). 139–155. 18 indexed citations

16.

Guibourdenche, M, et al.. (1996). Epidemics of serogroup ANeisseria meningitidisof subgroup III in Africa, 1989–94. Epidemiology and Infection. 116(2). 115–120. 46 indexed citations

17.

Chelsom, Julia, et al.. (1994). Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features. The Lancet. 344(8930). 1111–1115. 193 indexed citations

18.

Høiby, E. Arne, G Bjune, L O Frøholm, et al.. (1991). The Norwegian meningococcal serogroup B outer membrane vesicle vaccine protection trials: case tracing, meningococcal antigen detection and serological diagnosis.. PubMed. 14(2). 107–21; discussion 121. 14 indexed citations

19.

Haimanot, Redda Tekle, Dominique A. Caugant, Daniel Fekadu, et al.. (1990). Characteristics of Serogroup A Neisseria meningitidis Responsible for an Epidemic in Ethiopia, 1988-89. Scandinavian Journal of Infectious Diseases. 22(2). 171–174. 22 indexed citations

20.

Caugant, Dominique A., K Bøvre, Peter Gaustad, et al.. (1986). Multilocus Genotypes Determined by Enzyme Electrophoresis of Neisseria meningitidis Isolated from Patients with Systemic Disease and from Healthy Carriers. Microbiology. 132(3). 641–652. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact